| β | 95% CI | P | Adjusted P †|
---|---|---|---|---|
Constant | 0.047 | (0.004,0.090) | 0.034 | Â |
Health condition* | ||||
 General population | Reference |  |  |  |
 Infectious and parasitic diseases | 0.000 | (− 0.088, 0.088) | 0.998 | 1.000 |
 Cancer | 0.014 | (− 0.049,0.077) | 0.655 | 1.000 |
 Endocrine, nutritional and metabolic disorders | 0.024 | (− 0.024, 0.073) | 0.330 | 0.997 |
 Mental and behavioral disorders | 0.004 | (− 0.044, 0.052) | 0.876 | 1.000 |
 Nervous system disorders | 0.054 | (0.040, 0.148) | 0.256 | 0.986 |
 Diseases of the ear | 0.127 | (0.046, 0.209) | 0.002 | 0.024 |
 Circulatory system disorders | − 0.050 | (− 0.181, 0.082) | 0.459 | 1.000 |
 Respiratory system disorders | 0.021 | (− 0.054, 0.096) | 0.583 | 1.000 |
 Musculoskeletal disorders | − 0.030 | (− 0.086, 0.026) | 0.288 | 0.994 |
 Genitourinary system disorders | 0.098 | (0.031, 0.166) | 0.005 | 0.055 |
 Conditions originating in the perinatal period | − 0.010 | (− 0.066, 0.045) | 0.711 | 1.000 |
 Congenital malformations | − 0.020 | (− 0.121, 0.082) | 0.703 | 1.000 |
 Injury, poisoning and other consequences of external causes | − 0.127 | (− 0.255, 0.002) | 0.053 | 0.490 |
 Chronic illness | − 0.095 | (− 0.170, − 0.020) | 0.013 | 0.154 |
Valuation methods | ||||
 VAS | Reference |  |  |  |
 SG | 0.007 | (− 0.040, 0.054) | 0.767 | 1.000 |
 TTO | − 0.059 | (− 0.127, 0.008) | 0.083 | 0.658 |
 EQ-5D | − 0.110 | (− 0.163, − 0.058) |  < 0.001 | 0.001 |
 EQ-5D-Y | − 0.045 | (− 0.095, 0.006) | 0.085 | 0.672 |
 HUI2 | − 0.067 | (− 0.111, − 0.024) | 0.002 | 0.025 |
 HUI3 | − 0.020 | (− 0.052, 0.013) | 0.228 | 0.967 |
 CHU-9D | − 0.041 | (− 0.094, 0.012) | 0.132 | 0.837 |
 QWB | − 0.041 | (− 0.158, 0.076) | 0.489 | 1.000 |
 PAHOM | − 0.104 | (− 0.175, − 0.034) | 0.004 | 0.048 |
Proxy types | ||||
 Proxy assessment by parents | Reference |  |  |  |
 Proxy assessment by clinicians | 0.083 | (0.016, 0.151) | 0.016 | 0.185 |
 Proxy assessment by caregivers | − 0.061 | (− 0.114, − 0.008) | 0.025 | 0.274 |